174 results
Page 4 of 9
8-K
EX-10.1
pztbak e5e8
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.5
msob qkhj0e
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.4
t2b azajw
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
sxdfsp64im2xsixx
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K/A
EX-10.3
uokwfn70o9wqs9yu
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
zcr1lw5bkya
10 Sep 13
Other Events
12:00am
8-K
EX-4.4
znrb9ffv8b9g4e
25 Jan 13
Theravance Announces Closing of Public Offering of $287.5 Million of Convertible Subordinated Notes
12:00am
424B5
lw57 pjfign0y8od1yi
18 Jan 13
Prospectus supplement for primary offering
12:00am
S-3ASR
EX-4.4
mzx5aha4
16 Jan 13
Automatic shelf registration
12:00am
S-3ASR
whiry5sb3u0ru3m
16 Jan 13
Automatic shelf registration
12:00am